Hydroxytyrosol Dosage Guide: Protocols, Calculator & Safety
Everything you need to know about Hydroxytyrosol dosing — protocols, safety, and where to buy.
Dosage Calculator
Calculate exact dosing for Hydroxytyrosol.
Dosing Protocols
BEGINNER PROTOCOL — Food-First Cardiovascular Foundation
Who this is for: Any healthy adult who wants to add evidence-based cardiovascular protection via the olive polyphenol pathway, without committing to a dedicated supplement stack. This is the default approach for most BodyHackGuide users.
Dose and form: High-polyphenol extra-virgin olive oil as the primary delivery vehicle. Target intake: 2–3 tablespoons (25–40 mL) daily, used raw on food — drizzle on salads, finish soups, dip bread, add to yogurt or oatmeal after plating. Avoid using premium EVOO for high-heat frying (the polyphenols degrade above 180°C).
Quality parameters: Buy high-polyphenol EVOO with (a) harvest date specified on the label within 12–18 months of purchase, (b) single cultivar or single-region specification (Koroneiki, Picual, Coratina, Moraiolo, Arbequina preferred for polyphenol content), (c) dark glass bottle, (d) ideally third-party certification (NAOOA, COI, DOP/PDO). Expect to pay $20–$40 per 500 mL for therapeutic-quality EVOO. The peppery throat bite and optional single cough on swallowing (the oleocanthal sign) are reliable quality indicators.
Timeline: Continuous daily intake; not cycled. Effects develop gradually — measurable oxidized-LDL reductions in 3–6 weeks per EUROLIVE; endothelial function improvement in 4–8 weeks; cardiovascular event reduction in years (PREDIMED timescale).
Verification: Annual lipid panel including apoB and LDL-P (particle count) if available; home blood pressure monitoring; subjective palate test (high-polyphenol EVOO has a distinctive peppery finish — if your oil tastes flat or buttery, it's probably low-polyphenol and you should upgrade).
Foundation dietary layer: Pair EVOO intake with a broader Mediterranean pattern — daily vegetables and fruits, legumes 3–5x/week, fish 2x/week, moderate nuts (30 g/day), modest red wine with meals (optional, if culturally appropriate and not contraindicated), minimal refined carbohydrates and ultra-processed foods. EVOO alone on a Western-junk-food diet will not reproduce PREDIMED.
Cost: $0.50–$1.50 per day for 3 Tbsp of premium EVOO, or roughly $15–$40 per month. This is the entry-level cardiovascular-support line.
INTERMEDIATE PROTOCOL — Targeted Supplementation for Specific Indications
Who this is for: Users with identified cardiovascular or metabolic risk factors — pre-hypertension or stage-1 hypertension, elevated oxidized LDL, metabolic syndrome, NAFLD, post-statin CoQ10 depletion — where the dietary EVOO approach is insufficient or where precise polyphenol dose control is desired.
Primary intervention: Continue the dietary EVOO foundation (3 Tbsp/day high-polyphenol) and add one of:
- Standardized olive leaf extract 500 mg BID with meals, standardized to 15–20% oleuropein (yielding ~75–100 mg/day absorbed hydroxytyrosol-equivalents). This is the Susalit-trial-aligned dose for hypertension support. Brands: Barlean's Olive Leaf Complex, Gaia Herbs Olive Leaf (Standardized), Comvita Olive Leaf Extract, NOW Foods Olive Leaf.
- OR direct standardized hydroxytyrosol isolate 10–25 mg BID with meals (20–50 mg/day total). Branded ingredients: Hytolive (Genosa), Benolea (Frutarom). Brands: Life Extension Hydroxytyrosol, Jarrow Formulas Olive Leaf Extract (with HT specified), Thorne Hytolive (where available).
Choose one approach — stacking direct HT on top of olive leaf extract is generally redundant for cardiovascular indications.
Stacking layer (optional): Add one or two complementary cardiovascular-support agents based on indication:
- For endothelial function / FMD: L-citrulline 6 g/day + beetroot extract
- For lipid / oxidative stress: vitamin E 400 IU mixed tocopherols + CoQ10 100 mg/day
- For inflammation: omega-3 EPA+DHA 2 g/day + curcumin phytosome 500 mg BID
- For metabolic: berberine 500 mg TID with meals (if glucose elevation)
Timeline: Baseline labs before starting; repeat at 12 weeks for biomarker response assessment. Expect modest BP reduction (3–8 mmHg systolic), triglyceride reduction (5–15%), and improved FMD in 8–12 weeks if the intervention is working. Continue indefinitely if tolerated and effective.
Verification: Quarterly home BP tracking, 12-week labs (lipid panel with apoB, hsCRP, HbA1c if metabolic), annual advanced lipid panel (oxidized LDL if available, LDL-P count). Coordinate with primary-care physician; do not replace prescription antihypertensives or statins without physician discussion.
Cost: Dietary EVOO ~$30/month + olive leaf extract or Hytolive ~$25–$45/month = roughly $55–$75/month total.
ADVANCED PROTOCOL — Maximum Polyphenol Density for Performance and Longevity Focus
Who this is for: Users with longevity-oriented stacks, athletic-performance applications, post-cardiovascular-event prevention, or dedicated focus on oxidative-stress and mitochondrial-support protocols. Also appropriate for users with genetic risk factors (family history of early cardiovascular disease, APOE4, elevated Lp(a)) pursuing maximum evidence-aligned mitigation.
Multi-layer polyphenol delivery:
- Dietary EVOO: 3–4 Tbsp/day high-polyphenol premium EVOO (>500 mg/kg total polyphenols), split across meals.
- Standardized olive leaf extract: 500 mg BID (15–20% oleuropein) for sustained polyphenol density.
- Direct hydroxytyrosol isolate: 25 mg pre-training or pre-meal for acute bolus (Hytolive or Benolea).
- Complementary polyphenol subclass coverage: quercetin 500 mg, hesperidin 500 mg, apigenin 50 mg, pterostilbene 50 mg, EGCG 400 mg (separated from iron-rich meals), curcumin phytosome 500 mg BID.
Mitochondrial-support layer: CoQ10 ubiquinol 200 mg/day + PQQ 20 mg/day + nicotinamide riboside 500 mg/day + urolithin-a 500 mg/day (for mitophagy).
Cardiovascular-support layer: Omega-3 EPA+DHA 3 g/day, vitamin E mixed tocopherols 400 IU, magnesium glycinate 400 mg/day, K2 MK-7 180 mcg/day, vitamin D3 4,000 IU/day.
Athletic-performance overlay (if relevant): Pre-training (60–90 min pre): direct HT 25 mg + L-citrulline 8 g + caffeine if tolerated. Post-training: high-polyphenol EVOO on post-workout meal, protein-centered recovery meal with polyphenol-rich vegetables and fruits.
Timeline: This is a maintenance-intensity longevity stack, not a short-term intervention. Continuous year-round, with optional seasonal cycling of the nicotinamide riboside and urolithin-A layers (12 weeks on, 4 weeks off) if desired.
Verification: Annual comprehensive labs — advanced lipid panel with oxidized LDL, apoB, LDL-P, Lp(a); hsCRP; HbA1c; fasting insulin and HOMA-IR; ApoE genotype (if not done); coronary artery calcium score every 3–5 years; carotid intima-media thickness ultrasound if available. Track trends, not single values.
Integration with medications. This protocol is additive to evidence-indicated prescription therapy (statins, antihypertensives, metformin, SGLT2 inhibitors, etc.) — not a replacement. Users with multiple prescription medications should review the stack with their cardiologist or preventive-medicine physician to check for interactions and adjust dosing of hypertension or antidiabetic medications if the supplement stack produces measurable additive effects on BP or glucose.
Cost: $120–$250/month depending on brand selection, total duration of use, and inclusion of advanced add-ons. This is a serious commitment and should be matched to serious indications.
Stopping rules: Reduce or discontinue if you develop persistent orthostatic symptoms, unexplained GI intolerance, allergic reactions, or any unexpected lab abnormality. Taper stepwise — reduce direct HT first, then olive leaf extract, then simplify the polyphenol stack — rather than stopping everything at once.
Commonly Stacked With
Hydroxytyrosol stacks particularly well with other cardiovascular, metabolic, and mitochondrial-support interventions — the pharmacology hits multiple complementary nodes and layers cleanly with other evidence-backed agents.
With oleuropein / olive leaf extract — direct synergy. This is the most obvious stack, but also the most misunderstood. Oleuropein is hydrolyzed to hydroxytyrosol during digestion, so taking both does not double the hydroxytyrosol delivery — it increases the hydroxytyrosol pool from two sources. The practical combination: high-polyphenol EVOO (3 Tbsp/day) as dietary foundation, plus standardized olive leaf extract (500 mg BID standardized to 15–20% oleuropein) for additional polyphenol density in specific indications. Adding direct hydroxytyrosol isolate (10–25 mg/day Hytolive or Benolea) on top is redundant for most users unless dose precision is specifically required.
With vitamin E — tocopherol regeneration. Hydroxytyrosol reduces the tocopheroxyl radical back to active α-tocopherol, extending the functional lifetime of vitamin E in LDL particles and cell membranes. This synergy is a major reason EVOO (which contains both hydroxytyrosol and vitamin E in the same lipid matrix) outperforms either molecule individually. For supplemental stacking: 400 IU mixed tocopherols daily with hydroxytyrosol 20 mg BID. Avoid high-dose α-tocopherol alone (>800 IU), which has shown mortality signals in some meta-analyses and displaces γ-tocopherol.
With CoQ10 / ubiquinol — mitochondrial antioxidant network. Hydroxytyrosol operates in the cytosolic and aqueous compartments; CoQ10 operates in the mitochondrial inner membrane. Together, they provide a complete intracellular antioxidant envelope. Particularly relevant for users on statin therapy (which reduces endogenous CoQ10 synthesis) or with heart failure, fatigue, or age-related mitochondrial decline. Stack: CoQ10 ubiquinol 100–200 mg/day + hydroxytyrosol 20–30 mg/day.
With other polyphenols — complementary subclass coverage. The polyphenol superfamily is divided into subclasses with distinct mechanistic emphases. A comprehensive polyphenol-longevity stack covers multiple subclasses: quercetin 500 mg/day (flavonol, senolytic and mast-cell stabilizer), hesperidin 500 mg/day (flavanone, venotonic and vascular), apigenin 50 mg/day (flavone, CD38 inhibition for NAD+ preservation), pterostilbene 50 mg/day (stilbene, SIRT1), EGCG 400 mg/day (catechin, separated from iron), and hydroxytyrosol 20 mg/day (secoiridoid, cardiovascular). Each hits a different node; the combination is more physiologically complete than any single polyphenol.
With omega-3 fatty acids — complementary cardiovascular protection. Hydroxytyrosol protects LDL from oxidation and improves endothelial function; omega-3 EPA/DHA lowers triglycerides, reduces inflammation, and stabilizes cardiac rhythm. The combination is synergistic on cardiovascular risk. A practical stack: hydroxytyrosol 20 mg/day + omega-3 (EPA + DHA 2 g/day from fish oil or algal oil) + high-polyphenol EVOO 2 Tbsp/day + routine Mediterranean dietary pattern.
With L-citrulline or dietary nitrate — eNOS stack. Hydroxytyrosol upregulates eNOS expression and activity; L-citrulline and dietary nitrate provide the substrate for NO production. The combination maximizes endothelial NO bioavailability and is particularly relevant for athletes, erectile-function support, or borderline hypertension management. Stack: hydroxytyrosol 20 mg/day + L-citrulline 6–8 g/day + beetroot extract 500 mg/day (or whole-food beets).
With magnesium and potassium — blood pressure stack. For users addressing hypertension without medication, combining hydroxytyrosol's modest BP-lowering effect with magnesium glycinate (400 mg/day), potassium (from diet primarily — leafy greens, fruit, potatoes), and lifestyle (DASH/Mediterranean pattern, sodium restriction, exercise, weight loss) produces additive systolic reductions. Not a replacement for antihypertensive medication in stage-2 hypertension.
With curcumin — anti-inflammatory stack. Both target NF-κB-mediated inflammation through different molecular interactions. Combination for inflammatory conditions (joint pain, inflammatory bowel, post-exercise recovery) at hydroxytyrosol 20 mg/day + curcumin phytosome 500 mg BID. Add oleocanthal-rich EVOO (3 Tbsp/day raw) for additional COX inhibition.
What NOT to stack: High-dose acute vitamin C (>2 g single dose) immediately around hydroxytyrosol dosing may accelerate polyphenol oxidation in the gut — space by 2–4 hours if both are used. Avoid combining with pharmacologic catecholamine modulators (MAO inhibitors, high-dose L-dopa in Parkinson's) without physician oversight — theoretical interactions not confirmed clinically. Users on warfarin or DOACs should monitor INR on HT initiation at high doses (>50 mg/day), though the anticoagulation interaction signal is weak.
Timing. With meals is standard and preferred — the lipid matrix improves the absorption of polyphenol conjugates and reduces transient GI effects. For stacks with multiple polyphenols, a single consolidated "polyphenol meal" (breakfast or dinner) is simpler than scattered intake and captures most of the benefit. Athletic-performance stacks may schedule hydroxytyrosol pre-exercise (60–90 minutes before training) to align peak plasma levels with exercise-induced oxidative stress.
Side Effects & Safety
Contraindications
Hydroxytyrosol has essentially no absolute contraindications, consistent with its status as a dietary polyphenol with centuries of population-scale consumption through olive oil intake. Relative contraindications and cautions: **True olive allergy.** Rare but documented, often cross-reacting with olive pollen (a major Mediterranean aeroallergen). Users with confirmed olive fruit or olive pollen allergy with systemic reactions should avoid olive leaf extract and direct hydroxytyrosol isolates. Culinary EVOO use may be tolerated but should be discussed with an allergist. Mild oral allergy syndrome (perioral tingling, lip itching) with olives does not contraindicate supplemental use but warrants initiating at low doses and monitoring for progression. **Concurrent antihypertensive therapy.** Hydroxytyrosol (and olive leaf extract) produces modest BP reductions (typically 3–8 mmHg systolic in normotensive or pre-hypertensive subjects, larger in the Susalit stage-1 hypertensive cohort). For users on multiple antihypertensive medications — ACE inhibitors, ARBs, beta-blockers, calcium channel blockers, diuretics, or combinations — adding supplemental HT may produce additive BP effects, particularly orthostatic hypotension in elderly patients. Practical approach: start at the low end of the HT dose range (10 mg/day direct HT or 500 mg/day olive leaf extract), monitor home BP daily for 2–4 weeks, and coordinate dose adjustments with the prescribing physician. Orthostatic symptoms (lightheadedness on standing) require dose reduction of either HT or the prescription regimen. **Concurrent antidiabetic therapy.** Modest insulin-sensitizing effects may add to insulin, sulfonylureas, meglitinides, or SGLT2 inhibitors. Monitor blood glucose during the first 2–4 weeks of HT initiation, particularly if you have frequent hypoglycemia episodes on your current regimen. The signal is modest; clinically significant hypoglycemia from HT supplementation is rare. **Pregnancy.** Dietary EVOO intake during pregnancy is universally safe and probably beneficial — consistent with broader Mediterranean-diet epidemiology. Pharmacologic-dose supplemental hydroxytyrosol or olive leaf extract during pregnancy has not been formally studied. Avoid supplemental forms during pregnancy or discuss with an obstetrician; continue dietary EVOO intake. **Lactation.** Dietary EVOO during lactation is safe and encouraged. Supplemental HT or olive leaf extract during lactation lacks formal evaluation; probably fine but should be discussed with the pediatrician, particularly in the first 3 months of breastfeeding. **Pediatric.** No formal pediatric studies exist. Dietary EVOO and table-olive intake are safe and traditional in Mediterranean children. Supplemental HT is not recommended in children or adolescents without pediatrician oversight. **Bleeding disorders and anticoagulation.** Weak anti-platelet activity at very high HT doses (>50 mg/day direct HT or >1500 mg/day olive leaf extract) may add to aspirin, NSAIDs, warfarin, or direct oral anticoagulants (DOACs). The clinical signal is essentially zero at standard doses and only weakly present at high doses. Warfarin users on high-dose supplementation should check INR 2–3 weeks after starting. DOAC users do not need formal monitoring at standard doses. Stop high-dose supplementation 7 days before major surgery as a standard precaution. **Severe hypotension or decompensated heart failure.** Avoid adding HT supplementation if you have borderline-low BP or are actively being titrated on multiple cardiac medications for decompensated heart failure. Wait until the acute regimen is stable, then discuss addition with your cardiologist. **MAO inhibitors and tricyclic antidepressants — theoretical concern.** Hydroxytyrosol is structurally similar to catecholamines and is metabolized in part via COMT and MAO. Theoretical interactions with MAO inhibitors (phenelzine, tranylcypromine, moclobemide) or tricyclic antidepressants could affect plasma catecholamine levels or serotonergic signaling. Clinical evidence for this interaction is absent — standard HT doses have not shown effects on BP extremes, heart rate, or mood biomarkers in trials. Initiate at low doses and monitor for adrenergic symptoms (palpitations, sweating, anxiety, BP lability) if on these medications. **Very high doses (>100 mg/day direct HT).** Isolated case reports of palpitations, headache, or GI intolerance at high supplemental doses. Not a contraindication but a rationale to limit direct HT to 10–50 mg/day in most indications. **Contraindications that are NOT present:** Liver or kidney disease (HT is well-tolerated in mild-moderate hepatic or renal impairment); cardiovascular disease broadly (HT is indicated, not contraindicated); diabetes (HT is adjunct, not contraindicated); pregnancy loss history (no signal); cancer history (no signal — HT is mechanistically neutral or favorable in most cancer models); autoimmune disease (no signal); prior statin intolerance (HT is fine alongside statins). **Drug interactions — minimal.** Olive polyphenols are weak and clinically insignificant inhibitors of most CYP450 enzymes at supplemental doses. In contrast to grapefruit juice, olive oil and olive products do not meaningfully affect CYP3A4-metabolized drugs (calcium channel blockers, statins, immunosuppressants, many psychiatric medications). Theoretical weak inhibition of P-glycoprotein and OATP1A2 at very high HT doses could marginally affect absorption of narrow-therapeutic-index drugs like digoxin or fexofenadine — space dosing by 2–4 hours as a simple hedge if one of these is concurrent. **Red flags that warrant stopping.** New orthostatic symptoms that don't resolve with dose reduction; unexplained easy bruising or bleeding on supplementation; new allergic symptoms (rash, urticaria, angioedema); unexplained hypoglycemia in diabetics; severe GI intolerance (persistent nausea, abdominal pain, diarrhea); palpitations or arrhythmias. Stop the supplement and consult your clinician before resuming. **Not a replacement for indicated prescription therapy.** Hydroxytyrosol and olive leaf extract are adjuncts — not replacements — for prescription antihypertensives in stage-2 hypertension (BP >140/90), insulin in type-1 diabetes, statin therapy in high-ASCVD-risk individuals with elevated apoB, antiplatelets after acute coronary syndrome, or antibiotics in confirmed bacterial infections. They are valid adjuncts to prescription therapy with clinician coordination, but abrupt replacement of indicated drug therapy with polyphenol supplementation risks major adverse cardiovascular events. **Not contraindicated but commonly confused:** Hydroxytyrosol is NOT the same as olive oil (it is the active polyphenol within it); NOT the same as oleuropein (it is the absorbed metabolite of oleuropein); NOT the same as hydroxychloroquine (a malaria/autoimmune drug with completely different pharmacology); NOT the same as tyrosine (an amino acid); NOT the same as dopamine, despite structural similarity. The grapefruit–drug interaction does NOT apply to olive products.
Additional Notes
Hydroxytyrosol dose depends on which form you use and which indication you're targeting. Three practical routes: dietary EVOO, olive leaf extract, or direct HT isolate.
(1) Dietary extra-virgin olive oil. The EFSA health-claim threshold is 5 mg hydroxytyrosol and derivatives per 20 g EVOO serving, which corresponds to roughly 250 mg/kg total polyphenols. High-polyphenol premium EVOO at 300–500+ mg/kg total polyphenols delivers 6–12 mg HT-equivalents per 20 g (22 mL). The PREDIMED-aligned intake is 50 mL/day (~4 Tbsp) of ~300 mg/kg polyphenol EVOO, delivering ~15 mg/day HT-equivalents. For routine use, 25–40 mL/day (2–3 Tbsp) of premium high-polyphenol EVOO delivers 8–20 mg/day HT-equivalents — at or above the EFSA threshold.
Verifying polyphenol content: Premium producers increasingly publish polyphenol panels; aim for >400 mg/kg total polyphenols for therapeutic intake. If the label doesn't specify, the palate test is reliable — high-polyphenol EVOO has peppery throat bite, green/grassy aroma notes, and may cause a single cough on swallowing. Flat, buttery, bland oils are low-polyphenol regardless of 'extra virgin' labeling.
Cooking: Polyphenols degrade above 180°C (deep-frying, high-heat searing). For therapeutic polyphenol intake, use EVOO raw or in moderate-heat cooking (sauté, roast up to 180°C). Reserve premium high-polyphenol EVOO for raw application; a separate cheaper EVOO for routine cooking is fine.
(2) Standardized olive leaf extract. Typical clinical trial dosing is 500 mg BID of olive leaf extract standardized to 15–20% oleuropein (yielding 150–200 mg/day oleuropein, converting via gastric and intestinal hydrolysis to ~75–100 mg/day absorbed hydroxytyrosol-equivalents). This is the Susalit 2011 hypertension trial dose. Higher doses (1000 mg BID) are used in some inflammation and metabolic studies. Morning and evening dosing with meals is standard. Choose products that specify oleuropein percentage explicitly; non-standardized leaf powder varies unpredictably.
(3) Direct hydroxytyrosol isolate. Typical dose range is 10–50 mg/day, usually divided BID with meals. The most studied branded ingredients are Hytolive (Genosa, Spain) and Benolea (Frutarom / IFF). Common commercial formulations deliver 5–25 mg HT per capsule or serving. For general cardiovascular support: 10–20 mg/day. For athletic performance or metabolic indications: 25–50 mg/day. Doses up to 100 mg/day have been studied short-term without adverse-event signals but benefits plateau above 25–50 mg/day. Dosing with meals is preferred for GI tolerance and to leverage the lipid matrix for absorption of HT conjugates.
(4) Whole olives. Table olives deliver 5–30 mg hydroxytyrosol-equivalents per 30 g serving, varying by processing method. Naturally-fermented Greek-style, Spanish-style, or water-cured varieties retain more polyphenols than lye-cured black olives. Whole olives are an excellent Mediterranean-diet component but not a primary therapeutic polyphenol delivery vehicle at typical intakes.
Timing. With meals is standard. The lipid matrix improves absorption of polyphenol conjugates and reduces transient GI effects. For direct HT isolates, dose 30–60 minutes before a fat-containing meal for optimal absorption. For athletic performance applications, schedule pre-training dosing 60–90 minutes before exercise to align plasma peaks with exercise-induced oxidative stress.
Duration and cycling. Continuous daily use is the evidence-aligned pattern — consistent with dietary polyphenol exposure. Cycling (8–12 weeks on, 2–4 weeks off) is used by some practitioners for olive leaf extract but lacks evidence of superiority over continuous dosing and is probably not necessary. For direct HT isolate, continuous use at 10–25 mg/day is appropriate for most users; higher doses (50 mg/day) can be cycled in 6–12 week blocks for specific indications.
Ceiling dose. The highest hydroxytyrosol doses in clinical trials have been 100 mg/day for 12–24 weeks without meaningful adverse-event signals. Dietary EVOO intake up to 60–80 mL/day (the Cretan longevity cohort intake) is well-tolerated long-term. There is no compelling rationale to exceed 50 mg/day supplemental HT in any standard indication.
Dose titration. Start at the low end of the target range (EVOO 1–2 Tbsp/day, olive leaf extract 500 mg/day, direct HT 10 mg/day) for 2 weeks, then increase to target dose. This minimizes transient GI effects and allows assessment of BP or glucose response before committing to the full dose.
Special situations:
- Pre-exercise (athletic performance): Direct HT 25 mg 60–90 min pre-training, combined with L-citrulline 6–8 g and adequate hydration. Post-training recovery is better served by whole-food polyphenol-rich meals than additional supplementation.
- Post-cardiovascular event: Coordinate with cardiologist. Dietary EVOO 3 Tbsp/day + olive leaf extract 500 mg BID as adjunct to evidence-based prescription therapy (statin, ACE inhibitor / ARB, beta-blocker, antiplatelet) — not replacement.
- Pregnancy and lactation: Dietary EVOO is universally safe and beneficial; pharmacologic-dose supplementation should be avoided or discussed with an obstetrician.
- Pediatric: No formal pediatric studies; dietary EVOO and table olives are safe and traditional. Supplemental HT is not recommended in children without pediatrician oversight.
Practical product selection. For EVOO: McEvoy Ranch, California Olive Ranch Destination Series, Fresh-Pressed Olive Oil Club (T.J. Robinson), Laudemio Frescobaldi, Pianogrillo, Atsas Organics, Oliviers & Co. For olive leaf extract: Barlean's Olive Leaf Complex, Gaia Herbs Olive Leaf, Comvita Olive Leaf, NOW Foods Olive Leaf, Swanson Olive Leaf. For direct hydroxytyrosol: Life Extension Hydroxytyrosol (Hytolive), Thorne (where available), specialty sports-nutrition brands using Hytolive or Benolea. Always verify the standardized polyphenol content on the label — products without specified HT or oleuropein content are not reliably dosable.
Frequently Asked Questions
What is the recommended Hydroxytyrosol dosage?
Dosage for Hydroxytyrosol varies by protocol. Consult a qualified healthcare provider.
How often should I take Hydroxytyrosol?
Administration frequency depends on the specific protocol. Consult current research literature.
Does Hydroxytyrosol need to be cycled?
Cycling requirements depend on the protocol. Follow established research guidelines.
What are Hydroxytyrosol side effects?
Hydroxytyrosol is exceptionally well-tolerated. Across thousands of patient-years of supplemental exposure in published RCTs and centuries of dietary exposure through EVOO consumption, the adverse-event profile is essentially indistinguishable from placebo at standard dietary and supplemental doses. **Common, mild, and transient (estimated <5% of users):** - Mild GI discomfort (bloating, loose stools) when initiating high-dose HT (>25 mg/day) on an empty stomach — resolves with taking with meals - Transient mild headache in the first 1–3 days of high-dose HT initiation — typically resolves with continued use or dose reduction - Mild lightheadedness in blood-pressure-sensitive individuals, particularly those on antihypertensives — reflects the modest BP-lowering effect **Rare and dose-related (estimated <1% of users):** - Heartburn or GI reflux at high doses on an empty stomach - Dizziness or orthostatic symptoms with concurrent antihypertensive therapy - Rare allergic-type reactions in users with confirmed olive or olive-pollen allergy — skin flushing, pruritus, mild angioedema - Rare reports of palpitations at very high doses (>100 mg/day) — mechanism unclear, possibly related to catecholamine structural mimicry **Theoretical concerns not confirmed in the clinical database:** - Because hydroxytyrosol is a catechol structurally similar to catecholamines, theoretical concerns about interaction with MAO, COMT, dopamine signaling, or norepinephrine pathways have been raised — but clinical trials have not observed significant effects on mood, blood pressure extremes, heart rate, or catecholamine biomarkers at standard doses. Users on MAO inhibitors or tricyclic antidepressants should initiate at low doses and monitor for adrenergic symptoms. - Very high doses (>150 mg/day) in rodent models have shown some pro-oxidant effects on iron mobilization — not observed clinically at supplemental doses but a reminder that polyphenol antioxidants are biphasic. **What does NOT occur:** Hepatotoxicity (no transaminitis signal at any studied dose), nephrotoxicity, hematologic suppression, teratogenicity in animal reproductive studies, dependency or withdrawal, sleep disruption, or cognitive impairment. The safety database is cleaner than for many prescription drugs at equivalent exposure levels. **Special populations.** Pregnancy and lactation — dietary EVOO intake is universally safe and beneficial; pharmacologic-dose supplemental HT during pregnancy has not been formally studied and should be avoided or discussed with an obstetrician. Children — no formal pediatric studies, though dietary EVOO and table-olive intake is safe and traditional in Mediterranean children. Elderly — well-tolerated at all studied ages; monitor BP if adding to multi-drug antihypertensive regimens. Renal or hepatic impairment — no dose adjustments required for mild-moderate impairment; severe impairment has not been formally studied. **Long-term safety.** PREDIMED's 4.8-year follow-up on the high-polyphenol EVOO arm and the broader Mediterranean-diet epidemiology provide population-scale long-term safety data at the dietary dose range. Supplemental HT at 25–50 mg/day has been studied up to 16 weeks in RCTs. Longer-duration supplemental dosing is inferred to be safe based on dietary-dose safety and the mechanistic profile, but formal multi-year supplemental trials have not yet been conducted.
Where can I buy Hydroxytyrosol?
Visit our vendor directory to find trusted sources for Hydroxytyrosol.
Free 2026 Peptide Cheat Sheet — 50 pages, PDF
Dosing, reconstitution, stacks, half-lives, and vendor trust tiers. The reference we wish we had on day one.
